Pulmonary and cardiovascular effects of nanoparticles

Nanotoxicology: Characterization, Dosing and Health Effects

Volumn , Issue , 2007, Pages 267-297

  Donaldson, Ken ^a   Newby, David E ^b   MacNee, William ^a   Duffin, Rodger ^a   Lucking, Andrew J ^b   Mills, Nicholas L ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882766796     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (144)

1. Royal Society and Royal Academy of Engineering. Nanoscience and Nanotechnologies: Opportunities and Uncertainties. London: The Royal Society 2004.
2. Seaton A, MacNee W, Donaldson K, Godden D. Particulate air-pollution and acute health-effects. Lancet 1995; 345: 176-8.
3. Utell MJ, Frampton MW. Acute health effects of ambient air pollution: the ultrafine particle hypothesis. J Aerosol Med 2000; 13: 355-9.
4. Donaldson K, Tran L, Jimenez L, Duffin R, Newby DE, Mills N, et al. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure 1. Part Fibre Toxicol 2005; 2: 10.
5. Quality of Urban Air Review Group. Airborne Particulate Matter in the United Kingdom. Third Report of the Quality of Urban Air Review Group. Quality of Urban Air Review Group, 1996.
6. Brunekreef B, Holgate ST. Air pollution and health. Lancet 2002; 360: 1233-42.
7. Pope CA, Dockery DW. Epidemiology of particle effects. In: Holgate ST, Samet JM, Koren HS, Maynard RL, eds. Air Pollution and Health. San Diego: Academic Press, 1999: 673-705.
8. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001; 103: 2810-5.
9. Gong HJr, Linn WS, Terrell SL, Clark KW, Geller MD, Anderson KR, et al. Altered heart-rate variability in asthmatic and healthy volunteers exposed to concentrated ambient coarse particles. Inhal Toxicol 2004; 16: 335-43.
10. Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W. Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability. Eur Respir J Suppl 2003; 40: 76s-80.
11. Lippmann M, Ito K, Hwang JS, Maciejczyk P, Chen LC. Cardiovascular effects of nickel in ambient air. Environ Health Perspect 2006; 114: 1662-9.
12. Ghio AJ, Kim C, Devlin RB. Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am J Respir Crit Care Med 2000; 162: 981-8.
13. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 2002; 105: 1534-6.
14. Kunzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, et al. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect 2005; 113: 201-6.
15. Schlesinger RB, Cassee F. Atmospheric secondary inorganic particulate matter: the toxicological perspective as a basis for health effects risk assessment. Inhal Toxicol 2003; 15: 197-235.
16. Pope CA, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995; 151: 669-74.
17. de Hartog JJ, Hoek G, Mirme A, Tuch T, Kos GP, ten BrinkHM, et al. Relationship between different size classes of particulate matter and meteorology in three European cities. J Environ Monit 2005; 7: 302-10.
18. Air Quality Expert Group. Particulate Matter in the United Kingdom. London: The Department of Environment, Food and Rural Affairs, 2005.
19. Elder A, Gelein R, Finkelstein J, Phipps R, Frampton M, Utell M, et al. Onroad exposure to highway aerosols. 2. Exposures of aged, compromised rats. Inhal Toxicol 2004; 16(Suppl 1): 41-53.
20. Kittelson DB, Watts WF, Johnson JP, Remerowki ML, Ische EE, Oberdorster G, et al. On-road exposure to highway aerosols. 1. Aerosol and gas measurements. Inhal Toxicol 2004; 16(Suppl 1): 31-9.
21. Afshari A, Matson U, Ekberg LE. Characterization of indoor sources of fine and ultrafine particles: a study conducted in a full-scale chamber. Indoor Air 2005; 15: 141-50.
22. Dennekamp M, Howarth S, Dick CA, Cherrie JW, Donaldson K, Seaton A. Ultrafine particles and nitrogen oxides generated by gas and electric cooking. Occup Environ Med 2001; 58: 511-6.
23. Donaldson K, Jimenez LA, Rahman I, Faux SP, MacNee W, Gilmour PS, et al. Respiratory health effects of ambient air pollution particles: role of reactive species. In: Vallyathan V, Shi X, Castranova V, eds. Oxygen/Nitrogen Radicals: Lung Injury and Disease in Lung Biology in Health and Disease. New York: Marcel Dekker, 2004.
24. Donaldson K, Stone V, Borm PJ, Jimenez LA, Gilmour PS, Schins RP, et al. Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10). Free Radic Biol Med 2003; 34: 1369-82.
25. Miyabara Y, Yanagisawa R, Shimojo N, Takano H, Lim HB, Ichinose T, et al. Murine strain differences in airway inflammation caused by diesel exhaust particles. Eur Respir J 1998; 11: 291-8.
26. Tsurudome Y, Hirano T, Yamato H, Tanaka I, Sagai M, Hirano H, et al. Changes in levels of 8-hydroxyguanine in DNA, its repair and OGG1 mRNA in rat lungs after intratracheal administration of diesel exhaust particles. Carcinogenesis 1999; 20: 1573-6.
27. Nordenhall C, Pourazar J, Blomberg A, Levin JO, Sandstrom T, Adelroth E. Airway inflammation following exposure to diesel exhaust: a study of time kinetics using induced sputum. Eur Respir J 2000; 15: 1046-51.
28. Ichinose T, Yajima Y, Nagashima M, Takenoshita S, Nagamachi Y, Sagai M. Lung carcinogenesis and formation of 8-hydroxy-deoxyguanosine in mice by diesel exhaust particles. Carcinogenesis 1997; 18: 185-92.
29. Arimoto T, Yoshikawa T, Takano H, Kohno M. Generation of reactive oxygen species and 8-hydroxy-20-deoxyguanosine formation from diesel exhaust particle components in L1210 cells. Jpn J Pharmacol 1999; 80: 49-54.
30. Bonvallot V, Baeza-Squiban A, Baulig A, Brulant S, Boland S, Muzeau F, et al. Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epithelial cells and induce cytochrome p450 1A1 expression. Am J Respir Cell Mol Biol 2001; 25: 515-21.
31. Hirano S, Furuyama A, Koike E, Kobayashi T. Oxidative-stress potency of organic extracts of diesel exhaust and urban fine particles in rat heart microvessel endothelial cells. Toxicology 2003; 187: 161-70.
32. Li N, Venkatesan MI, Miguel A, Kaplan R, Gujuluva C, Alam J, et al. Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J Immunol 2000; 165: 3393-401.
33. Nel AE, az-Sanchez D, Li N. The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr Opin Pulm Med 2001; 7: 20-6.
34. McNeilly JD, Jimenez LA, Clay MF, MacNee W, Howe A, Heal MR, et al. Soluble transition metals in welding fumes cause inflammation via activation of NF-kappaB and AP-1. Toxicol Lett 2005; 158: 152-7.
35. Marano F, Boland S, Bonvallot V, Baulig A, Baeza-Squiban A. Human airway epithelial cells in culture for studying the molecular mechanisms of the inflammatory response triggered by diesel exhaust particles. Cell Biol Toxicol 2002; 18: 315-20.
36. Hiura TS, Kaszubowski MP, Li N, Nel AE. Chemicals in diesel exhaust particles generate reactive oxygen radicals and induce apoptosis in macrophages. J Immunol 1999; 163: 5582-91.
37. Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Jibiki I, Takizawa H, et al. Diesel exhaust particles activate p38 MAP kinase to produce interleukin 8 and RANTES by human bronchial epithelial cells and N-acetylcysteine attenuates p38 MAP kinase activation. Am J Respir Crit Care Med 2000; 161: 280-5.
38. Takizawa H, Ohtoshi T, Kawasaki S, Kohyama T, Desaki M, Kasama T, et al. Diesel exhaust particles induce NF-kappa B activation in human bronchial epithelial cells in vitro: importance in cytokine transcription. J Immunol 1999; 162: 4705-11.
39. Gilmour PS, Rahman I, Donaldson K, MacNee W. Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. Am J Physiol Lung Cell Mol Physiol 2003; 284: L533-40.
40. Terada N, Hamano N, Maesako KI, Hiruma K, Hohki G, Suzuki K, et al. Diesel exhaust particulates upregulate histamine receptor mRNA and increase histamine-induced IL-8 and GM-CSF production in nasal epithelial cells and endothelial cells. Clin Exp Allergy1999; 29: 52-9 [see comments].
41. Salvi SS, Nordenhall C, Blomberg A, Rudell B, Pourazar J, Kelly FJ, et al. Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am J Respir Crit Care Med 2000; 161: 550-7.
42. Yang HM, Ma JC, Castranova V, Ma JH. Effects of diesel exhaust particles on the release of interleukin-1 and tumor necrosis factor-alpha from rat alveolar macrophages. Exp Lung Res 1997; 23: 269-84.
43. Steerenberg PA, Zonnenberg JJ, Dormans JA, Joon PT, Wouters IM, vanBree L, et al. Diesel exhaust particles induced release of interleukin 6 and 8 by (primed) human bronchial epithelial cells (BEAS2B) in vitro. ExpLung Res 1998; 24: 85-100.
44. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004; 109: 2655-71.
45. Brook RD, Brook JR, Rajagopalan S. Air pollution: the “Heart” of the problem. Curr Hypertens Rep 2003; 5: 32-9.
46. Donaldson K, Mills N, MacNee W, Robinson S, Newby D. Role of inflammation in cardiopulmonary health effects of PM. Toxicol Appl Pharmacol 2005; 207: 483-8.
47. Viles-Gonzalez JF, Anand SX, Valdiviezo C, Zafar MU, Hutter R, Sanz J, et al. Update in atherothrombotic disease. Mt Sinai J Med 2004; 71: 197-208.
48. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
49. Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 2000; 293: 31-52.
50. Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002; 39: 935-42.
51. Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. Longterm air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 2005; 294: 3003-10.
52. Lippmann M, Gordon T, Chen LC. Effects of subchronic exposures to concentrated ambient particles in mice. IX. Integral assessment and human health implications of subchronic exposures of mice to CAPs. Inhal Toxicol 2005; 17: 255-61.
53. Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. Passage of inhaled particles into the blood circulation in humans. Circulation 2002; 105: 411-4.
54. Mills N, Amin N, Robinson S, Davies J, de la Fuent JM, Boon NA, et al.: Inhaled 99mTechnetium-labeled carbon nanoparticles do not translocate into the circulation in man. Am J Resp Crit Care Med 2005, submitted.
55. Davies MJ. Coronary disease: the pathophysiology of acute coronary syndromes. Heart 2000; 83: 361-6.
56. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 1555-64.
57. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
58. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51.
59. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-4.
60. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999; 99: 1411-5.
61. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-9.
62. Eijnden-Schrauwen Y, Kooistra T, de Vries RE, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995; 85: 3510-7.
63. Brommer EJ. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards. Thromb Res 1984; 34: 109-15.
64. Fox KA, Robison AK, Knabb RM, Rosamond TL, Sobel BE, Bergmann SR. Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation 1985; 72: 1346-54.
65. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 2005; 112: 3930-6.
66. Radomski A, Jurasz P, onso-Escolano D, Drews M, Morandi M, Malinski T, et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 2005. 66.a. Circulation article (details TK).
67. Nemmar A, Nemery B, Hoet PH, Vermylen J, Hoylaerts MF. Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am J Respir Crit Care Med 2003; 168: 1366-72.
68. Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 1999; 99: 1780-87.
69. Pope CA, III, Muhlestein JB, May HT, Renlund DG, Anderson JL, Horne BD. Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution 1. Circulation 2006: 114: 2443-8.
70. Lanki T, de Hartog. JJ, Heinrich J, Hoek G, Janssen NA, Peters A, et al. Can we identify sources of fine particles responsible for exercise-induced ischemia on days with elevated air pollution? The ULTRA study. Environ Health Perspect 2006; 114: 655-60.
71. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women 1. N Engl J Med 2007; 356: 447-58.
72. Mills NL, Tornqvist H, Gonzalez M, Robinson SD, MacNee W, Blomberg A, et al. Adverse cardiovascular effects of air pollution in patients with coronary heart disease. J Am Coll Cardiol, abstract (in press).
73. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-81.
74. Tsuji H, Venditti FJ, Jr., Manders ES, Evans JC, Larson MG, Feldman CL, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994; 90: 878-83.
75. Kleiger RE. Heart rate variability and mortality and sudden death post infarction. J Cardiovasc Electrophysiol 1995; 6: 365-7.
76. Pope CA, III, Verrier RL, Lovett EG, Larson AC, Raizenne ME, Kanner RE, et al. Heart rate variability associated with particulate air pollution [see comments]. Am Heart J 1999; 138: 890-9.
77. Liao D, Creason J, Shy C, Williams R, Watts R, Zweidinger R. Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect 1999; 107: 521-5.
78. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 2001; 104: 986-91.
79. Creason J, Neas L, Walsh D, Williams R, Sheldon L, Liao D, et al. Particulate matter and heart rate variability among elderly retirees: the Baltimore 1998 PM study. J Expo Anal Environ Epidemiol 2001; 11: 116-22.
80. Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, et al. Ambient Pollution and Heart Rate Variability. Circulation 2000; 101: 1267-73.
81. Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W. Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability 14. Eur Respir J Suppl 2003; 40: 76s-80s.
82. Wellenius GA, Saldiva PH, Batalha JR, Krishna Murthy GG, Coull BA, Verrier RL, et al. Electrocardiographic changes during exposure to residual oil fly ash (ROFA) particles in a rat model of myocardial infarction. Toxicol Sci 2002; 66: 327-35.
83. Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, et al. Air pollution and incidence of cardiac arrhythmia [see comments]. Epidemiology 2000; 11: 11-7.
84. Campen MJ, Nolan JP, Schladweiler MC, Kodavanti UP, Costa DL, Watkinson WP. Cardiac and thermoregulatory effects of instilled particulate matter-associated transition metals in healthy and cardiopulmonary-compromised rats. J Toxicol Environ Health A 2002; 65: 1615-31.
85. Godleski JJ, Verrier RL, Koutrakis P, Catalano P, Coull B, Reinisch U, et al. Mechanisms of morbidity and mortality from exposure to ambient air particles. Res Rep Health Eff Inst 2000; 5-88.
86. Bellmann B, Muhle H, Creutzenberg O, Mermelstein R. Irreversible pulmonary changes induced in rat lung by dust overload. Environ Health Perspect 1992; 97: 189-91.
87. Morrow PE. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 1992; 113: 1-12.
88. Mauderly JL, Cheng YS, Snipes MB. Particle overload in toxicological studies: friend or foe. J Aerosol Med 1990; 3(Suppl 1): S169-87.
89. Morrow PE. Possible mechanisms to explain dust overloading of the lungs. Fundam Appl Toxicol 1988; 10: 369-84.
90. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 2000; 12: 1113-26.
91. Cullen RT, Tran CL, Buchanan D, Davis JM, Searl A, Jones AD, et al. Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol 2000; 12: 1089-11.
92. Driscoll KE. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. Inhal Toxicol 1996; 8(Suppl): 139-53.
93. Oberdorster G, Ferin J, Soderholm S, Gelein R, Baggs R, Morrow PE. Increased pulmonary toxicity of inhaled ultrafine particles: due to overload alone? Inhal Toxicol 1999; 38: 295-302.
94. Gilmour PS, Ziesenis A, Morrison ER, Vickers MA, Drost EM, Ford I, et al. Pulmonary and systemic effects of short-term inhalation exposure to ultrafine carbon black particles. Toxicol Appl Pharmacol 2004; 195: 35-44.
95. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 2004; 61: 442-7.
96. Hohr D, Steinfartz Y, Schins RP, Knaapen AM, Martra G, Fubini B, et al. The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO 2 in the rat. Int J Hyg Environ Health 2002; 205: 239-44.
97. Duffin R, Clouter A, Brown D, Tran CL, MacNee W, Stone V, et al. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann Occup Hyg 2002; 46(Suppl 1): 242-5.
98. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol 2002; 184: 172-9.
99. Stone V, Shaw J, Brown DM, MacNee W, Faux SP, Donaldson K. The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function. Toxicol In Vitro 1998; 12: 649-59. 1998.
100. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, et al. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 2005; 38: 1080-92.
101. Stone V, Tuinman M, Vamvakopoulos JE, Shaw J, Brown D, Petterson S, et al. Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur Respir J 2000; 15: 297-303.
102. Brown DM, Donaldson K, Borm PJ, Schins RP, Dehnhardt M, Gilmour P, et al. Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 2004; 286: L344-53.
103. Tamaoki J, Isono K, Takeyama K, Tagaya E, Nakata J, Nagai A. Ultrafine carbon black particles stimulate proliferation of human airway epithelium via EGF receptor-mediated signaling pathway. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1127-33.
104. Timblin CR, Shukla A, Berlanger I, Berube KA, Churg A, Mossman BT. Ultrafine airborne particles cause increases in protooncogene expression and proliferation in alveolar epithelial cells. Toxicol Appl Pharmacol 2002; 179: 98-104.
105. Donaldson K, Tran CL. An introduction to the short-term toxicology of respirable industrial fibers. Mutat Res 2004; 553: 5-9.
106. Nyberg K, Johansson U, Rundquist I, Camner P. Estimation of pH in individual alveolar macrophage phagolysosomes. Exp Lung Res 1989; 15: 499-510.
107. Hesterberg TW, Miiller WC, Musselman RP, Kamstrup O, Hamilton RD, Thevenaz P. Biopersistence of man-made vitreous fibers and crocidolite asbestos in the rat lung following inhalation. Fundam Appl Toxicol 1996; 29: 267-79.
108. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005; 207: 221-31.
109. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 2004; 67: 87-107.
110. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of singlewall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004; 77: 126-34.
111. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004; 77: 117-25.
112. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. Unusual inflammatory and fibrogenic pulmonary responses to singlewalled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289: L698-708.
113. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005; 155: 377-84.
114. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 2003; 66: 1909-26.
115. Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, et al. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 2005; 39: 1378-83.
116. Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, et al. Multiwalled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett 2006; 160: 121-6.
117. Cui D, Tian F, Ozkan CS, Wang M, Gao H. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 2005; 155: 73-85.
118. Manna SK, Sarkar S, Barr J, Wise K, Barrera EV, Jejelowo O, et al. Singlewalled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett 2005; 5: 1676-84.
119. Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, et al. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol Lett 2006; 165: 88-100.
120. Sayes CM, Fortner JD, Guo W, Lyon D, Colvin VL, et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 2004; 4: 1881-7.
121. Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006.
122. Mirkov SM, Djordjevic AN, Andric NL, Andric SA, Kostic TS, Bogdanovic GM, et al. Nitric oxide-scavenging activity of polyhydroxylated fullerenol, C 60 (OH) 24. Nitric Oxide 2004; 11: 201-7.
123. Corona-Morales AA, Castell A, Escobar A, Drucker-Colin R, Zhang L. Fullerene C60 and ascorbic acid protect cultured chromaffin cells against levodopa toxicity. J Neurosci Res 2003; 71: 121-6.
124. Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F. [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett 2005; 5: 2578-85.
125. Lee YT, Chiang LY, Chen WJ, Hsu HC. Water-soluble hexasulfobutyl[60]-fullerene inhibit low-density lipoprotein oxidation in aqueous and lipophilic phases. Proc Soc Exp Biol Med 2000; 224: 69-75.
126. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006; 114: 165-72.
127. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2005; 83: 377-85.
128. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004; 15: 79-86.
129. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002; 298: 1759-62.
130. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003; 300: 1434-6.
131. Soto KJ, Carrasco A, Powell TG, Garza KM, Murr LE. Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterised by transmission electron microscopy. J Nanoparticle Res 2005; 7: 145-69.
132. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005; 19: 975-83.
133. Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 2005.
134. Dick CA, Brown DM, Donaldson K, Stone V. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal Toxicol 2003; 15: 39-52.
135. Yamawaki H, Iwai N. Mechanisms underlying nano-sized air-pollutionmediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ J 2006; 70: 129-40.
136. Don Porto CA, Hoet PH, Verschaeve L, Schoeters G, Nemery B. Genotoxic effects of carbon black particles, diesel exhaust particles, and urban air particulates and their extracts on a human alveolar epithelial cell line (A549) and a human monocytic cell line (THP-1). Environ Mol Mutagen 2001; 37: 155-63.
137. Schins RP. Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol 2002; 14: 57-78.
138. de Kok TM, Hogervorst JG, Briede JJ, van Herwijnen MH, Maas LM, Moonen EJ, et al. Genotoxicity and physicochemical characteristics of trafficrelated ambient particulate matter. Environ Mol Mutagen 2005; 46: 71-80.
139. Knaapen AM, Borm PJ, Albrecht C, Schins RP. Inhaled particles and lung cancer. Part A: Mechanisms. Int J Cancer 2004; 109: 799-809.
140. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
141. Chen M, von Mikecz A. Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp Cell Res 2005; 305: 51-62.
142. Geiser M, Rothen-Rutlshauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. Ultrafine particles cross cellular membranes by non-phagocyticmechanisms in lungs and in cultured cells. Environ Health Perspect 2005, in press.
143. Donaldson K, Beswick PH, Gilmour PS. Free radical activity associated with the surface of particles: a unifying factor in determining biological activity? Toxicol Lett 1996; 88: 293-8.
144. Pope CA, III, Dockery DW. Epidemiology of particle effects. In: Holgate ST, Samet JM, Koren HS, Maynard RL. eds. Air Pollution and Health. San Diego: Academic Press, 1999: 673-705.